Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 525 of 2051 entries
View as:

A Study of MK-2206 in Combination With Trastuzumab and Lapatinib for the Treatment of HER2+ Solid Tumors (MK-2206-015)

Phase: N/A Priority: Normal
NCT ID: NCT00963547 Org: User:
Start: 09/15/09 End: 12/22/11 Due: 12/22/12

Safety Study of CAELYX in Patients With Metastatic Breast Cancer Previously Treated With Anthracyclines (Study P04057)(TERMINATED)

Phase: N/A Priority: Normal
NCT ID: NCT00779285 Org: User:
Start: 02/28/06 End: 08/31/06 Due: 08/31/07

A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002)

Phase: N/A Priority: Normal
NCT ID: NCT00753415 Org: User:
Start: 08/31/08 End: 04/30/11 Due: 04/30/12

MK6186 in HIV-1 Infected Patients (MK-6186-007 AM2)

Phase: N/A Priority: Normal
NCT ID: NCT01152255 Org: User:
Start: 10/31/10 End: 06/30/11 Due: 06/30/12

MK0859 Dose-Ranging Study (0859-003)

Phase: N/A Priority: Normal
NCT ID: NCT00325455 Org: User:
Start: 06/30/06 End: 03/31/07 Due: 03/31/08

Comparative Study of Ertapenem Versus Another Antibiotic in the Treatment of Diabetic Foot Infections in Adults (0826-034)

Phase: N/A Priority: Normal
NCT ID: NCT00229112 Org: User:
Start: 04/30/01 End: 04/30/04 Due: 04/30/05

A Study to Assess the Clinical Effects of Navarixin in Participants With Psoriasis (MK-7123-009)

Phase: N/A Priority: Normal
NCT ID: NCT00684593 Org: User:
Start: 06/01/07 End: 10/01/07 Due: 10/01/08

Valopicitabine When Administered Alone and in Combination With Interferon to Treatment-Naive Patients With Hepatitis C

Phase: N/A Priority: Normal
NCT ID: NCT00120835 Org: User:
Start: 07/31/04 End: - Due: -

A Study of MK0777 Gel Extrusion Module (GEM) in the Treatment of Outpatients With Generalized Anxiety Disorder (0777-019)

Phase: N/A Priority: Normal
NCT ID: NCT00703833 Org: User:
Start: 09/30/02 End: 02/28/03 Due: 02/28/04

Farnesyl Protein Transferase Inhibitor (FPTI) in Combination With Docetaxel in Advanced Solid Tumors (Study P01964)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00040547 Org: User:
Start: 06/30/01 End: 02/29/04 Due: 02/28/05

Effect of Indinavir Plus Two Other Anti-HIV Drugs on Blood Clotting in HIV-Positive Males With Hemophilia

Phase: N/A Priority: Normal
NCT ID: NCT00002386 Org: User:
Start: - End: - Due: -

A Study of INS365 Ophthalmic Solution in Patients With Moderate to Severe Dry Eye Disease

Phase: N/A Priority: Normal
NCT ID: NCT00679718 Org: User:
Start: 01/31/00 End: 07/31/00 Due: 07/31/01

A Bridging Trial Comparing Sugammadex (Org 25969) at Reappearance of T2 in Japanese and Caucasian Participants. Part A: Japanese Participants (P05956)

Phase: N/A Priority: Normal
NCT ID: NCT00591409 Org: User:
Start: 01/03/06 End: 12/18/06 Due: 12/18/07

A Pharmacokinetic Evaluation Study in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00210093 Org: User:
Start: 04/30/03 End: 05/31/03 Due: 05/31/04

Perioperative Pembrolizumab (MK-3475) Plus Cystectomy or Perioperative Pembrolizumab Plus Enfortumab Vedotin Plus Cystectomy Versus Cystectomy Alone in Participants Who Are Cisplatin-ineligible or Decline Cisplatin With Muscle-invasive Bladder Cancer (MK-3475-905/KEYNOTE-905/EV-303)

Phase: N/A Priority: Normal
NCT ID: NCT03924895 Org: User:
Start: 07/24/19 End: 12/15/27 Due: 12/15/28

A Study to Evaluate the Efficacy of MK0719 in the Prevention of Postoperative Dental Pain (0719-002)

Phase: N/A Priority: Normal
NCT ID: NCT00424424 Org: User:
Start: 08/31/06 End: 01/31/07 Due: 01/31/08

Preservative-Free MK2452 (Tafluprost) for Open-Angle Glaucoma/Ocular Hypertension (MK2452-001)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT01026831 Org: User:
Start: 01/06/10 End: 09/17/10 Due: 09/17/11

Study of MK-7162 in Combination With Pembrolizumab (MK-3475) in Adult Participants With Advanced Solid Tumors (MK-7162-002)

Phase: N/A Priority: Normal
NCT ID: NCT03364049 Org: User:
Start: 12/06/17 End: 10/19/20 Due: 10/19/21

Pembrolizumab (MK-3475) Versus Placebo Following Surgery and Radiation in Participants With Locally Advanced Cutaneous Squamous Cell Carcinoma (MK-3475-630/KEYNOTE-630)

Phase: N/A Priority: Normal
NCT ID: NCT03833167 Org: User:
Start: 04/01/19 End: 12/22/25 Due: 12/22/26

An Active-Controlled Extension Study to NCT01155466 [P04938] and NCT01227265 [P07037] (P06153)

Phase: N/A Priority: Normal
NCT ID: NCT01215227 Org: User:
Start: 11/18/10 End: 07/16/13 Due: 07/16/14

A Study to Assess the Safety and Tolerability of Sitagliptin/Simvastatin Fixed-dose Combination (FDC) in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Monotherapy (MK-0431D-312)

Phase: N/A Priority: Normal
NCT ID: NCT01702298 Org: User:
Start: 12/07/12 End: 05/29/13 Due: 05/29/14

Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of Pembrolizumab (MK-3475) in Chinese Participants With Non-Small-Cell Lung Cancer (MK-3475-032/KEYNOTE-032)

Phase: N/A Priority: Normal
NCT ID: NCT02835690 Org: User:
Start: 08/04/16 End: 12/31/21 Due: 12/31/22

Study of SCH 527123 in Subjects With Severe Asthma (Study P05109AM1)

Phase: N/A Priority: Normal
NCT ID: NCT01006161 Org: User:
Start: 01/31/10 End: 08/31/12 Due: 08/31/13

A Study of V503 Vaccine Given Concomitantly With REPEVAX™ in 11 to 15 Year Olds (V503-007)

Phase: N/A Priority: Normal
NCT ID: NCT01073293 Org: User:
Start: 04/22/10 End: 06/16/11 Due: 06/16/12

A Study of How MK-0736 Affects Arterial Plaque (0736-006)(TERMINATED)

Phase: N/A Priority: Normal
NCT ID: NCT00679055 Org: User:
Start: 03/31/07 End: 08/26/08 Due: 08/26/09